Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway.

Saved in:
Bibliographic Details
Title: Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway.
Authors: Jin Y; The 920th Hospital of the PLA Joint Logistic Support Force, Kunming, 650032, Yunnan, People's Republic of China., Liu Q; Air Force Medical Center, Chinese People's Liberation Army, Beijing, 100142, People's Republic of China., Sun B; Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, People's Republic of China., Li X; The 63650 Military Hospital, Chinese People's Liberation Army, Urumqi, 841700, China., Wu J; The 63650 Military Hospital, Chinese People's Liberation Army, Urumqi, 841700, China., Lin Z; The 63650 Military Hospital, Chinese People's Liberation Army, Urumqi, 841700, China., Ma Y; Department of Gastroenterology and Hepatology, The First Medical Centre, Chinese People's Liberation Army General Hospital, Beijing, 100853, People's Republic of China. mayan01@126.com., Jia H; Department of Quality Management, the 967th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, No. 80 Shengli Road, Xigang District, Dalian, 116021, Liaoning Province, People's Republic of China. 1290824203@qq.com.
Source: Discover oncology [Discov Oncol] 2024 Nov 25; Vol. 15 (1), pp. 709. Date of Electronic Publication: 2024 Nov 25.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-024-01572-2